Kurs
+1,79%
Kurs
+1,79%
Open
54,60
High
57,20
Low
54,60
Close
57,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
28,0 MNOK
Likviditet
28,0 MNOK
Rel. mcap
3,12%
Antal aktier
513 987
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-10 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | - | X-dag ordinarie utdelning GENT 0.40 NOK |
| 2025-05-07 | - | Kvartalsrapport 2025-Q1 |
| 2025-05-06 | - | Årsstämma |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-30 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2024-04-30 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-29 | - | Årsstämma |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-04 | - | Årsstämma |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2022-05-18 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-16 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2020-05-14 | - | Årsstämma |
| 2020-04-24 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-21 | - | Extra Bolagsstämma 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2018-07-13 | - | Extra Bolagsstämma 2018 |
| 2018-06-13 | - | X-dag ordinarie utdelning GENT 0.00 NOK |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-06-06 | - | Årsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2025-05-23 11:39:00
Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, sold 50,000 shares
in Gentian Diagnostics ASA (the "Company") on 23 May 2025 with settlement on 27
May 2025.
As a result of the transaction, companies wholly-owned by Rasmussengruppen AS
decreased their consolidated holding of shares in the Company from 793,421 to
743,421 shares, equal to a decrease from approximately 5.14% to approximately
4.82% of the votes and shares in the Company. The shares are held by Viola AS
(208,421 shares), Portia AS (300,000 shares) and Cressida AS (235,000 shares).
The above mentioned companies have no other rights to shares issued by the
Company.
This announcement is made in accordance with Section 4-2 of the Norwegian
Securities Trading Act.